E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 11
7 / 11Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Case Series
Online Published: 27 Dec 2021
 


Invasive Mucormycosis Following COVID-19 Pneumonia

Raghavendra Deshpande, Ipe Jacob, Pradeep Rangappa, Diwakar C, Karthik Rao.


Abstract
Invasive mucormycosis, a dreaded and debilitating fungal infection, referred to as ‘black fungus’ is being increasingly seen as a sequela of SARS-COV2 pneumonia. This is a highly invasive infection that arises on the background of an immunocompromised state and can cause extensive necrosis and bony destruction of the paranasal sinuses, orbit and surrounding tissues. In addition to antifungal drugs, treatment often involves aggressive surgical debridement including exenteration of the orbit. We describe four cases of mucormycosis that presented soon after treatment for SARS-COV2 pneumonia and their radiological findings and discuss risk factors, treatment and preventive measures.

Key words: Mucormycosis, Black fungus, maxillectomy, paranasal sinusitis


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Raghavendra Deshpande
Articles by Ipe Jacob
Articles by Pradeep Rangappa
Articles by Diwakar C
Articles by Karthik Rao
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Deshpande R, Jacob I, Rangappa P, C D, Rao K. Invasive Mucormycosis Following COVID-19 Pneumonia. Int J Med Rev Case Rep. 2021; 5(14): 22-26. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia

Web Style

Deshpande R, Jacob I, Rangappa P, C D, Rao K. Invasive Mucormycosis Following COVID-19 Pneumonia. https://www.mdpub.net/?mno=90853 [Access: October 14, 2024]. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia

AMA (American Medical Association) Style

Deshpande R, Jacob I, Rangappa P, C D, Rao K. Invasive Mucormycosis Following COVID-19 Pneumonia. Int J Med Rev Case Rep. 2021; 5(14): 22-26. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia


Vancouver/ICMJE Style

Deshpande R, Jacob I, Rangappa P, C D, Rao K. Invasive Mucormycosis Following COVID-19 Pneumonia. Int J Med Rev Case Rep. (2021), [cited October 14, 2024]; 5(14): 22-26. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia


Harvard Style

Deshpande, R., Jacob, . I., Rangappa, . P., C, . D. & Rao, . K. (2021) Invasive Mucormycosis Following COVID-19 Pneumonia. Int J Med Rev Case Rep, 5 (14), 22-26. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia


Turabian Style

Deshpande, Raghavendra, Ipe Jacob, Pradeep Rangappa, Diwakar C, and Karthik Rao. 2021. Invasive Mucormycosis Following COVID-19 Pneumonia. International Journal of Medical Reviews and Case Reports, 5 (14), 22-26. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia


Chicago Style

Deshpande, Raghavendra, Ipe Jacob, Pradeep Rangappa, Diwakar C, and Karthik Rao. "Invasive Mucormycosis Following COVID-19 Pneumonia." International Journal of Medical Reviews and Case Reports 5 (2021), 22-26. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia


MLA (The Modern Language Association) Style

Deshpande, Raghavendra, Ipe Jacob, Pradeep Rangappa, Diwakar C, and Karthik Rao. "Invasive Mucormycosis Following COVID-19 Pneumonia." International Journal of Medical Reviews and Case Reports 5.14 (2021), 22-26. Print. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia


APA (American Psychological Association) Style

Deshpande, R., Jacob, . I., Rangappa, . P., C, . D. & Rao, . K. (2021) Invasive Mucormycosis Following COVID-19 Pneumonia. International Journal of Medical Reviews and Case Reports, 5 (14), 22-26. doi:10.5455/IJMRCR.InvasiveMucormycosisFollowingCOVID-19Pneumonia


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500